Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229119 · ClinicalTrials.gov registry record · Phase 4
Vault Evaluation After ICL Implantation
A Phase 4 study of Nearsightedness, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06229119: Completed Phase 4 study of Nearsightedness, sponsored by Carolina Eyecare Physicians.
NCT06229119 is a Phase 4 study of Nearsightedness that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229119, a Phase 4 study of Nearsightedness, has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the lens vault after implantation of an implantable collamer lens (ICL). The ICL is designed to be implanted in front of the eye, without removing the natural lens. Because of this, it is also known as a phakic IOL. The ICL has already been approved by the U.S. Food and Drug Administration (FDA) to treat mid to high degrees of refractive errors such nearsightedness (also called myopia) with or without astigmatism. Once the artificial lens is implanted, a space between the ICL and the crystalline lens is created, which is called vault.
Primary Outcome
Difference between the predicted vault at the preoperative visit and the actual vault measured at the 1-month visit
Conditions Studied
Interventions
- DEVICE Implantable Collamer Lens
Study Locations (1)
South Carolina
- Helga Sandoval - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2024-08-23 |
| Phase | Phase 4 |
What the finished NCT06229119 record still lists
NCT06229119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Nearsightedness appearing as the primary indexed condition, and to 1 intervention - of which Implantable Collamer Lens is the first listed.
NCT06229119 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06229119 about?
NCT06229119 is a clinical study titled "Vault Evaluation After ICL Implantation". The purpose of this study is to evaluate the lens vault after implantation of an implantable collamer lens (ICL). The ICL is designed to be implanted in front of the eye, without removing the natural lens. Because of this, it is also known as a phakic IOL. The ICL has already been approved by the U....
What is the current status of trial NCT06229119?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2024-01-29. Estimated completion is 2024-08-23.
What conditions does trial NCT06229119 study?
This clinical trial studies the following conditions: Nearsightedness.
What interventions are being tested in trial NCT06229119?
The interventions under investigation include: Implantable Collamer Lens (DEVICE).
Who is sponsoring clinical trial NCT06229119?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06229119 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nearsightedness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06229119's enrollment target sits among peer trials
20 1753rd of 2000 higher than 168 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI